These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54. [Treatment of type II hyperlipoproteinemia--personal experiences]. Sznajderman M Pol Arch Med Wewn; 1978 Feb; 59(2):153-60. PubMed ID: 205843 [No Abstract] [Full Text] [Related]
55. A comparison of clofibrate and its derivative methyl clofenapate. Craig GM Atherosclerosis; 1972; 15(2):265-71. PubMed ID: 4666129 [No Abstract] [Full Text] [Related]
56. Application of the concanavalin A precipitation technique in an evaluation of fenofibrate action on cholesterolemia in IIa and IIb hyperlipemic subjects. Chicaud P; Demange J; Drouin P; Debry G Pharmacology; 1983; 26(2):90-4. PubMed ID: 6844393 [TBL] [Abstract][Full Text] [Related]
57. The hypocholesterolemic effect of terbufibrol and other drugs in normal and hypercholesterolemic baboons. Howard AN; Zschocke R; Löser R; Hofrichter G Atherosclerosis; 1979 Apr; 32(4):367-80. PubMed ID: 223594 [No Abstract] [Full Text] [Related]
58. [Cholesterol--now what?]. Smith P Tidsskr Nor Laegeforen; 2001 Mar; 121(9):1022. PubMed ID: 11354872 [No Abstract] [Full Text] [Related]
59. Carotenoids and vitamin A: the effect of hypocholesterolemic agents on serum levels. Probstfield JL; Lin TL; Peters J; Hunninghake DB Metabolism; 1985 Jan; 34(1):88-91. PubMed ID: 3965864 [TBL] [Abstract][Full Text] [Related]
60. The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group. JAMA; 1973 Nov; 226(6):652-7. PubMed ID: 4356847 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]